BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
cell-cell adhesion
,
Leukemia
,
Intestine
,
Amniocentesis
,
Valproic acid
,
rs2476601
,
SIRT1
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Gemtuzumab ozogamicin
(compound)
Summary
General Info
Genetic Markers
Most Correlated Genes
No genes found
Explore Genetic Markers Results
Pathway Enrichment
Most Correlated Biogroups
No biogroups found
Explore Pathway Enrichment Results
Curated Studies
Most Correlated Studies
No studies found
Explore Curated Studies Results
Literature
Most Relevant Literature
Gemtuzumab Ozogamicin in Acute Myeloid Leukemia: Efficacy, Toxicity, and Resistance Mechanisms-A Sys…
Addition of single dose gemtuzumab ozogamicin to intensive induction chemotherapy in core-binding fa…
Gemtuzumab ozogamicin (GO) as monotherapy and in combination with hypomethylation agents in the trea…
Negative Impact of Gemtuzumab Ozogamicin on CD33-Positive Early T-Cell Precursor Acute Lymphoblastic…
Genetic variation in DNA damage response pathway and response to Gemtuzumab Ozogamicin in pediatric …
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
CPX-351 in Combination With Gemtuzumab Ozogamicin in Newly Diagnosed AML
Phase I/II Study of Mitoxantrone, Etoposide and Gemtuzumab Ozogamicin for Acute Myeloid Leukemia
Gemtuzumab Ozogamicin in Treating Patients With Acute Myeloid Leukemia
Arsenic Trioxide and Gemtuzumab Ozogamicin in Treating Patients With Advanced Myelodysplastic Syndro…
Gemtuzumab Ozogamicin in Combination With A-HAM in Refractory AML (GO-A-HAM)
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ